Drug Makers Need Safe Harbor For Patient-Focused Development, Advocates Say
This article was originally published in The Pink Sheet Daily
Executive Summary
Biomedical reform legislation should include mechanism to encourage premarket patient engagement, National Health Council’s Marc Boutin says.